MetLife Investment Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-560
| Closed | -$57K | – | 2993 |
|
|
2023
Q2 | $57K | Hold |
560
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q1 | $99K | Sell |
560
-184
| -25% | -$32.5K | ﹤0.01% | 2559 |
|
|
2022
Q4 | $288K | Hold |
744
| – | – | ﹤0.01% | 2017 |
|
|
2022
Q3 | $251K | Buy |
744
+89
| +14% | +$30K | ﹤0.01% | 2141 |
|
|
2022
Q2 | $215K | Sell |
655
-103
| -14% | -$33.9K | ﹤0.01% | 2267 |
|
|
2022
Q1 | $331K | Buy |
758
+252
| +50% | +$110K | ﹤0.01% | 2037 |
|
|
2021
Q4 | $222K | Hold |
506
| – | – | ﹤0.01% | 1990 |
|
|
2021
Q3 | $281K | Hold |
506
| – | – | ﹤0.01% | 1861 |
|
|
2021
Q2 | $260K | Hold |
506
| – | – | ﹤0.01% | 1986 |
|
|
2021
Q1 | $395K | Hold |
506
| – | – | ﹤0.01% | 1661 |
|
|
2020
Q4 | $276K | Hold |
506
| – | – | ﹤0.01% | 1810 |
|
|
2020
Q3 | $232K | Hold |
506
| – | – | ﹤0.01% | 1779 |
|
|
2020
Q2 | $311K | Hold |
506
| – | – | ﹤0.01% | 1635 |
|
|
2020
Q1 | $241K | Hold |
506
| – | – | ﹤0.01% | 1591 |
|
|
2019
Q4 | $293K | Hold |
506
| – | – | ﹤0.01% | 1766 |
|
|
2019
Q3 | $333K | Buy |
506
+70
| +16% | +$46K | ﹤0.01% | 1639 |
|
|
2019
Q2 | $337K | Hold |
436
| – | – | ﹤0.01% | 1724 |
|
|
2019
Q1 | $308K | Hold |
436
| – | – | ﹤0.01% | 1739 |
|
|
2018
Q4 | $204K | Buy |
+436
| New | +$204K | ﹤0.01% | 1897 |
|
|
2018
Q3 | – | Sell |
-319
| Closed | -$220K | – | 2635 |
|
|
2018
Q2 | $220K | Hold |
319
| – | – | ﹤0.01% | 1886 |
|
|
2018
Q1 | $142K | Hold |
319
| – | – | ﹤0.01% | 2070 |
|
|
2017
Q4 | $140K | Buy |
+319
| New | +$140K | ﹤0.01% | 2107 |
|